← back to search

Erik Norberg

Karolinska Institutet · SE
Area of research
Molecular Biology · Epidemiology
Research interest
Research interests include Autophagy in Disease and Therapy, Mitochondrial Function and Pathology, Cancer, Hypoxia, and Metabolism, and Cell death mechanisms and regulation.
h-index
28
citations
9,443
works
58
NIH funding
primary concept
email

Recent publications

Chaperone-mediated autophagy regulates the metastatic state of mesenchymal tumors
EMBO Molecular Medicine 2025cited by 5position: middledoi
Mutant p53 as a Regulator and Target of Autophagy
Frontiers in Oncology 2021cited by 78position: middledoi
Quantitative proteomic analysis of temporal lysosomal proteome and the impact of the KFERQ-like motif and LAMP2A in lysosomal targeting
Autophagy 2021cited by 33position: middledoi
Systematic analysis reveals a functional role for STAMBPL1 in the epithelial–mesenchymal transition process across multiple carcinomas
British Journal of Cancer 2020cited by 29position: middledoi
Targetome analysis of chaperone-mediated autophagy in cancer cells
Autophagy 2019cited by 86position: middledoi
The role of mitochondria in metabolism and cell death
Biochemical and Biophysical Research Communications 2017cited by 701position: lastdoi
PHGDH Defines a Metabolic Subtype in Lung Adenocarcinomas with Poor Prognosis
Cell Reports 2017cited by 182position: lastdoi
Effect of Mutant p53 Proteins on Glycolysis and Mitochondrial Metabolism
Molecular and Cellular Biology 2017cited by 108position: middledoi
Characterization of the Role of the Malate Dehydrogenases to Lung Tumor Cell Survival
Journal of Cancer 2017cited by 53position: lastdoi
Degradation of HK2 by chaperone-mediated autophagy promotes metabolic catastrophe and cell death
The Journal of Cell Biology 2015cited by 123position: middledoi
Reactive oxygen species generated in different compartments induce cell death, survival, or senescence
Free Radical Biology and Medicine 2013cited by 132position: middledoi
Metabolic Signatures Uncover Distinct Targets in Molecular Subsets of Diffuse Large B Cell Lymphoma
Cancer Cell 2012cited by 527position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Helin Vakifahmetoglu-Norberg · Karolinska Institutet10 papers (2015–2025)Boxi Zhang · Karolinska Institutet6 papers (2017–2025)Amanda Tomie Ouchida · Albert Einstein College of Medicine5 papers (2017–2020)Merve Kacal · Karolinska Institutet3 papers (2019–2021)Gorbatchev Ambroise · Karolinska Institutet3 papers (2017–2020)Yuqing Hao · Chinese Academy of Medical Sciences & Peking Union Medical College3 papers (2019–2021)André Lima Queiroz · Cornell University2 papers (2017–2020)Yong Shi · China Pharmaceutical University2 papers (2021–2025)Per Hydbring · Karolinska Institutet2 papers (2017–2025)Cecilia Lindskog · Uppsala University2 papers (2020–2025)Marcin Iwanicki · Stevens Institute of Technology2 papers (2017–2025)Feng Zhou · Nanchang University1 papers (2012–2012)Yu Cai · Australian National University1 papers (2015–2015)Maria Genander · Karolinska Institutet1 papers (2025–2025)Vitaliy O. Kaminskyy · Karolinska Institutet1 papers (2025–2025)Zheng‐Jiang Zhu · Shanghai University1 papers (2015–2015)Jerker Widengren · Science for Life Laboratory1 papers (2017–2017)Hongguang Xia · Ministry of Education of the People's Republic of China1 papers (2015–2015)Dimitry Ofengeim · National Institute of Neurological Disorders and Stroke1 papers (2015–2015)Simon Ekman · Karolinska University Hospital1 papers (2025–2025)